Yüklüyor......
Primary diffuse large B-cell lymphoma of the bone: bendamustine and rituximab are able to overcome resistant disease
Primary bone lymphoma (PBL) is a rare disease for which specific therapeutic guidelines have not yet been established. Due to common appearance in the elderly and recurring relapses, new treatments are required. We report the case of multiple relapsed aggressive PBL effectively treated using Bendamu...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer International Publishing
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4101125/ https://ncbi.nlm.nih.gov/pubmed/25045615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2193-1801-3-342 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|